Dissemin
Language
العربيّة
Deutsch
English
Español
Suomi
Français
한국어
Македонски
Português
Português Brasileiro
Русский
Svenska
Türkçe
简体中文
繁體中文
Login
Dissemin
Gérard Zalcman
Baas et al., 2020
Links
ORCID
Tools
Export citation
×
Format
BibTeX
@article{Baas2020, author = {Baas, P. and Scherpereel, A. and Nowak, A. and Fujimoto, N. and Peters, S. and Tsao, A. and Mansfield, A. and Popat, S. and Jahan, T. and Antonia, S. and Oulkhouir, Y. and Bautista, Y. and Cornelissen, R. and Greillier, L. and Grossi, F. and Kowalski, D. M. and Rodriguez-Cid, J. and Aanur, P. and Baudelet, C. and Zalcman, G.}, month = {jan}, title = {First-Line Nivolumab plus Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743}, year = {2020} }
Export citation
Search in Google Scholar
First-Line Nivolumab plus Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743
Journal article published in 2020 by
P. Baas
,
A. Scherpereel
,
A. Nowak
,
N. Fujimoto
,
S. Peters
,
A. Tsao
,
A. Mansfield
,
S. Popat
,
T. Jahan
,
S. Antonia
,
Y. Oulkhouir
,
Y. Bautista
,
R. Cornelissen
,
L. Greillier
,
F. Grossi
and
other authors.
P. Baas
,
A. Scherpereel
,
A. Nowak
,
N. Fujimoto
,
S. Peters
,
A. Tsao
,
A. Mansfield
,
S. Popat
,
T. Jahan
,
S. Antonia
,
Y. Oulkhouir
,
Y. Bautista
,
R. Cornelissen
,
L. Greillier
,
F. Grossi
,
D. M. Kowalski
,
J. Rodriguez-Cid
,
P. Aanur
,
C. Baudelet
,
G. Zalcman
Show less
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text:
Unavailable
Preprint
: policy unknown
Upload
Postprint
: policy unknown
Upload
Published version
: policy unknown
Upload